ZURICH, April 28 Swiss stocks are set to open
higher on Thursday, in line with European markets expected to
track gains on Wall Street after the U.S. Federal Reserve
signalled it would not raise interest rates any time soon.
The Swiss blue-chip index SMI .SSMI was indicated to rise
46 points to 6,520 points, premarket data provided by bank
Clariden Leu showed.CLPRE
The following are some of the main factors expected to
affect Swiss stocks on Thursday:
Avastin, a cancer drug made by Roche, was about as effective
as the company's far more expensive eye drug Lucentis at
preventing vision loss in people with age-related macular
degeneration, The New York Times reported on Wednesday.
For related news click on [ROG.VX]
Logitech International, the world's largest computer mouse
maker, on Wednesday reported a steep quarterly profit drop and
predicted a rise in sales this year.
For related news, click on [LOGN.VX]
NOBEL BIOCARE NOBN.VX
The dental implant maker said it expected to return to
mid-single-digit growth, in line with the dental implant market,
by mid-2011 after posting a weaker-than-expected first-quarter
For related news, click on [NOBN.VX]
The Swiss drugmaker has received approval from the European
Union for a single-pill treatment of high blood pressure, the
group said on Thursday.
For related news click on [NOVN.VX]
Switzerland's biggest bank holds its annual general meeting.
For related news, click on [UBSN.VX]
COMPANY STATEMENTS [CNR-CH]
* Meyer Burger (MBTN.S) said it signed a contract worth over
70 million Swiss francs with a customer in Asia. [MBTN.S]
* Kuoni KUNN.S announces details of rights offering in
relation to the capital increase. [KUNN.S]
* Bucher Industries (BUCN.S) increased sales by 13 percent
or currency-adjusted 26 percent to 537 million Swiss francs in
the first quarter of 2011. [BUCN.S]
* Cytos CYTN.S published its first-quarter report.
* Looser Holding (LOHN.S) posted a 5.7 percent increase in
revenues after currency adjustments. [LOHN.S]
* ADB Group ADBN.S delivers a mid-period business update.
EQUITY RESEARCH [CH-RCH]
* Credit Suisse raises ABB ABBN.VX rating to Outperform
from Neutral, price target 26 Sfr from 24 Sfr-traders [ABBN.VX]
FOR COMPANIES TRADING EX-DIVIDEND, PLEASE CLICK ON:
.EX.S for all Swiss stocks
.EXSMI.S for blue chips
.EXNSMI.S for other stocks